Radiotherapy for breast cancer in the 21st century

Breast Journal

Volumn 16, Issue SUPPL. 1, 2010, Pages

  Powell, Simon ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

breast cancer; image guided radiotherapy; intensity modulated radiotherapy; partial breast irradiation; radiotherapy

Indexed keywords

BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONSERVATIVE TREATMENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MASTECTOMY; RADIATION DOSE; REVIEW;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY; POLY(ADP-RIBOSE) POLYMERASES; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN;

EID: 78649292498     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01001.x     Document Type: Review

References (19)

1. Taghian AG, Kozak KR, Doppke KP, et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2006; 64: 1092 -9.
2. Lawenda BD, Taghian AG, Kachnic LA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003; 56: 671 -80.
3. Coles CE, Moody AM, Wilson CB, Burnet NG,. Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part II -radiotherapy strategies to reduce radiation-induced late effects. Clin Oncol (R Coll Radiol) 2005; 17: 98 -110.
4. Powell S, Cooke J, Parsons C,. Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 1990; 18: 213 -20.
5. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010; 362: 513 -20.
6. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378 -87.
7. Haviland JS, Yarnold JR, Bentzen SM,. Hypofractionated radiotherapy for breast cancer. N Engl J Med 2010; 362:1843; author reply 43-4.
8. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 949 -55.
9. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956 -62.
10. Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010; 49: 24 -34.
11. Hall EJ, Wuu CS,. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83 -8.
12. Macdonald SM, Abi-Raad RF, Alm El-Din MA, et al. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys 2009; 75: 1297 -303.
13. Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 2005; 62: 1035 -9.
14. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441 -52.
15. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70?years of age or older with early breast cancer. N Engl J Med 2004; 351: 971 -7.
16. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087 -106.
17. Baselga J, Perez EA, Pienkowski T, Bell R,. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. Oncologist 2006; 11 (Suppl 1): 4 -12.
18. Fong PC, Boss DS, Yap TA, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361: 123 -34.
19. Willers H, Taghian AG, Luo CM, Treszezamsky A, Sgroi DC, Powell SN,. Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res 2009; 7: 1304 -9.